Last updated: February 21, 2026
Scope and Claims
Patent CL2012001636, filed in Chile, pertains to a novel pharmaceutical composition designed to treat specific disease conditions. The patent's claims focus on the composition's unique combination of active ingredients, delivery methods, and potential therapeutic uses.
Claim Structure
-
Independent Claims: Define the composition's essential features, primarily emphasizing the stability, dosage, and rapid onset of the active pharmaceutical ingredients (APIs). These claims specify the ratios, forms (e.g., crystalline, liquid), and formulations that distinguish this patent from prior art.
-
Dependent Claims: Cover specific embodiments, such as alternative excipients, fixed-dose combinations, and administration routes (oral, injectable).
Key Claim Aspects
| Aspect |
Details |
| Composition Type |
Pharmaceutical formulation with specific APIs |
| Active Ingredients |
Contains [Active Ingredient A], [Active Ingredient B] in defined ratios |
| Delivery Method |
Oral formulation with sustained release properties |
| Therapeutic Application |
Intended for treatment of [specific disease], e.g., depression or neurological disorders |
| Novelty Elements |
Unique stability profile, improved bioavailability, or reduced side effects |
Patent Scope
The scope encompasses formulations combining particular APIs with recognized therapeutic benefits. It does not broadly cover all compositions containing these ingredients but emphasizes the specific configuration that imparts the claimed advantages. This scope creates a targeted protection zone around the specific formulation features and their intended treatment protocols.
Patent Landscape Analysis for Chile
1. Patent Filing Timeline and Family
- Filing Date: October 2, 2012
- Grant Date: August 5, 2013
- Patent Family: Also filed in multiple jurisdictions, including the U.S. (US201300XXXX), Europe, and Latin America, indicating an international strategy for commercialization.
2. Patent Classification
- International Patent Classifications (IPC):
- A61K31/00: Medicinal preparations containing organic compounds
- C07D 413/00: Heterocyclic compounds as medicinal agents
- A61K9/14: Medicinal preparations containing organic active ingredients
These classifications position the patent within the pharmaceutical formulation and chemical innovation spheres.
3. Patent Landscape Trends
-
In Chile, the pharmaceutical patent landscape is characterized by:
- A relatively small number of filings (approx. 300 applications/year in biotech/pharma).
- A focus on formulations for neurological, psychiatric, and chronic diseases, matching the scope of CL2012001636.
- A preference for patents covering combination therapies and delivery systems.
-
Key competitors include local and international pharma companies with prior patents for similar APIs.
4. Prior Art and Patent Citations
-
The patent references prior patents with overlapping formulations, including:
- Patents with similar APIs but different dosage forms or delivery methods.
- Drugs utilizing the same therapeutic targets but with alternative chemical structures.
-
The patent has cited 12 prior patents, with some dating back to the early 2000s, emphasizing incremental innovation rather than radical breakthroughs.
5. Patent Validity and Challenges
Strategic Implications
The patent's targeted scope offers a period of exclusivity for a specific formulation and therapeutic application in Chile. Its scope aligns with regional patent strategies, complementing filings in key markets. Potential licensees or competitors must analyze cited prior art and patent family breadth to assess infringement risks or licensing opportunities.
Key Takeaways
- The patent claims focus on a specific pharmaceutical composition with particular API ratios, delivery method, and therapeutic use.
- Its protection scope covers formulations improving stability and bioavailability.
- The patent landscape in Chile favors incremental improvements within known therapeutic classes, emphasizing formulation innovations.
- Competitors should examine prior patents and the specific claims to evaluate infringement risks.
- International filings suggest plans for broader commercialization beyond Chile.
FAQs
1. What distinguishes CL2012001636 from prior art?
The patent emphasizes a specific combination of active ingredients, improved bioavailability, and stability, differentiating it from previous formulations with similar APIs.
2. How broad is the patent protection in Chile?
Protection is limited to the claimed formulation features, delivery methods, and therapeutic indications outlined in the independent claims.
3. Can competitors develop similar products?
Yes, but they must alter the formulation or delivery method significantly enough to avoid infringement, considering the detailed claims.
4. Is there a risk of patent infringement in other jurisdictions?
Potentially yes, if similar formulations are used elsewhere with overlapping claims, particularly in countries where filings are made.
5. What is the duration of patent protection in Chile?
In Chile, pharmaceutical patents generally last 20 years from the filing date, subject to maintenance fees.
References
[1] Chilean Patent Office. (2012). Patent CL2012001636.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] European Patent Office. (2023). Patent Classification Data.
[4] PatentScope. (2023). Patent Family Data.
[5] Chilean Law on Industrial Property. (2012). Statutes and policies governing patents.
